Frontierby eninvs

Language: EN · RU

US Large-Cap Stocks — Valuations, P/E & Dividends

Related guides: AI & Semiconductor Stocks by Valuation (2026) · The Cheapest US Oil & Gas Stocks (2026) · The Highest-Dividend US Stocks (2026) · The Cheapest Bank Stocks in the World (2026)

GDP growth 2026 (proj.) 2.3%Inflation YoY (proj.) 3.2%FX vs USD (3y avg p.a.) 0.0%Macro: IMF World Economic Outlook, April 2026 (Annex tables 1.1.2–1.1.4)
Our recommended portfolios
Performance & current holdings of our strategies for this market — why it makes sense to join.
GARP + accelerationbacktest CAGR +17% · excess +9%Paper-track · 15 Jun 2026
CAGR +17% · vs index +9% · Sharpe 0.81 · maxDD -32%
Day+0.8%S&P 500 -0.4%
Week-0.8%S&P 500 +0.1%
Month-2.6%S&P 500 -0.4%
By calendar year vs S&P 500
YearStratS&P 500Δ
2026*-2.2%+1.6%-3.7%
* partial year
Signal history & trades →
US Leaders (FVC)● live +327.9%Real track · Aug 2019
CAGR +15% · vs index +8% · Sharpe 0.82 · maxDD -32%
Day+0.2%S&P 500 -0.4%
Week+2.4%S&P 500 +0.1%
Month+2.0%S&P 500 -0.5%
YTD+4.7%S&P 500 +1.9%
By calendar year vs S&P 500
YearStratS&P 500Δ
2026*+4.5%+12.6%-8.0%
2025+29.6%+16.4%+13.2%
2024+37.6%+23.5%+14.1%
2023+58.3%+24.2%+34.1%
2022-17.1%-19.7%+2.6%
2021+30.6%+27.4%+3.2%
2020+14.2%+16.2%-2.0%
2019*+9.9%+0.3%+9.6%
* partial year; 2019 from 31 Aug 2019
Signal history & trades →

Sectors: Technology (19) · Health care (7) · Communication services (7) · Consumer staples (6) · Consumer discretionary (5) · Industrials (5)

Rows are ordered partly by extraction health (share of stable periods). Hover a row for OK / partial / error counts.

CompanyCountrySectorValue / upsideDiv. %FCF Yield LTMΔ revenue (NII for banks)Δ EBITDA (assets for financials)EV/EBITDA LTMP/E LTMP/B FYROE (ann.)
MICRON TECHNOLOGY INC
US_MU
USTechnology+76%0.1%1.2%345.7%737.0%16.6x22.7x21.1x43.5%
PEPSICO INC
US_PEP
USConsumer staples+60%4.2%5.9%6.4%89.5%12.9x18.1x9.3x54.0%
ORACLE CORP
US_ORCL
USTechnology+50%1.3%-5.1%20.6%32.0%14.7x27.2x22.6x41.4%
Dell Technologies Inc.
US_DELL
USUnited States — large cap (SEC filings)+46% 0.4%2.2%18.8% ▲19.4%26.4x40.6x
Broadcom Inc.
US_AVGO
USTechnology+39% 0.7%5.2%85.5% ▼164.6%32.1x45.4x21.4x44.4%
NVIDIA CORP
US_NVDA
USTechnology+37% 0.1%-0.0%85.2% ▼145.1%33.8x35.1x35.6x132.3%
UNITEDHEALTH GROUP INC
US_UNH
USHealth care+34% 2.3%5.8%0.4% ▲44.9%15.4x25.5x3.6x21.1%
TEXAS INSTRUMENTS INC
US_TXN
USTechnology+24% 2.2%3.5%22.8% ▲42.3%25.7x38.7x14.4x45.5%
CATERPILLAR INC
US_CAT
USIndustrials+22% 0.8%-1.1%24.0% ▲43.8%27.0x34.9x17.8x75.5%
Walt Disney Co
US_DIS
USCommunication services+22%1.4%0.7%6.8%18.0%9.7x22.1x1.7x3.2%
AMAZON COM INC
US_AMZN
USConsumer discretionary+22%-0.6%19.6%37.9%16.9x20.5x6.7x50.4%
Walmart Inc.
US_WMT
USConsumer staples+20%0.9%5.0%4.9%23.5%18.6x38.7x8.6x26.4%
Alphabet Inc.
US_GOOGL
USCommunication services+20%0.3%3.1%24.2%32.0%23.0x16.8x9.9x80.2%
RTX Corp
US_RTX
USIndustrials+19% 1.4%5.6%14.5% ▼20.7%19.9x35.2x4.2x12.9%
ANALOG DEVICES INC
US_ADI
USTechnology+19% 1.2%0.4%39.6% ▲31.6%28.3x42.9x5.2x5.3%
Apple Inc.
US_AAPL
USTechnology+19% 0.3%5.0%16.4% ▲25.7%27.6x36.7x37.1%
ELI LILLY & Co
US_LLY
USHealth care+18% 0.6%-0.0%47.7% ▲34.8%30.1x38.5x38.8x87.2%
Philip Morris International Inc.
US_PM
USConsumer staples+18%3.2%3.4%10.4%20.0%17.9x26.1x-112.7%
APPLIED MATERIALS INC /DE
US_AMAT
USTechnology+17%0.4%2.5%24.8%37.5%37.0x38.9x17.7x13.7%
AMGEN INC
US_AMGN
USHealth care+16% 2.3%4.2%9.5% ▼15.7%17.3x26.9x27.2x91.0%
ADVANCED MICRO DEVICES INC
US_AMD
USTechnology+16% 1.0%50.1% ▲534.8%81.4x121.4x12.4x14.0%
CISCO SYSTEMS, INC.
US_CSCO
USTechnology+14% 1.5%0.7%12.0% ▲21.5%27.2x32.9x9.2x9.2%
Palantir Technologies Inc.
US_PLTR
USTechnology+14% 2.6%92.8% ▲336.0%138.2x46.6%
MICROSOFT CORP
US_MSFT
USTechnology+13%0.7%0.1%18.3%20.4x27.8x10.8x69.0%
GE Vernova Inc.
US_GEV
USIndustrials+12% 0.2%1.3%21.9% ▲83.5%82.9x26.9x22.9x20.6%
Mastercard Inc
US_MA
USUnited States — large cap (SEC filings)+12% 0.6%2.1%14.1% ▲16.6%24.5x31.9x
Tesla, Inc.
US_TSLA
USConsumer discretionary+12% 2.7%25.5% ▼80.8%93.8x300.2x13.9x5.2%
KLA CORP
US_KLAC
USTechnology+11% 0.5%2.2%15.2% ▲20.8%40.1x50.2x89.5%
Arista Networks, Inc.
US_ANET
USTechnology+11% 0.7%37.7% ▲40.3%52.8x61.1x20.0x34.3%
NETFLIX INC
US_NFLX
USCommunication services+9%3.0%13.4%11.4%23.6x24.9x12.8x44.4%
COCA COLA CO
US_KO
USConsumer staples+9%2.4%4.1%6.7%8.3%25.8x26.5x11.8x50.7%
THERMO FISHER SCIENTIFIC INC.
US_TMO
USHealth care+9% 0.3%-2.6%10.5% ▲15.2%24.3x33.1x4.3x13.3%
COSTCO WHOLESALE CORP /NEW
US_COST
USConsumer staples+9% 0.6%2.6%11.6% ▲10.7%30.5x49.2x13.9x8.9%
JOHNSON & JOHNSON
US_JNJ
USHealth care+8%1.9%3.3%6.6%8.3%20.7x31.5x8.1x26.6%
AT&T INC.
US_T
USCommunication services+6%4.3%3.8%2.3%2.1%7.2x8.5x1.5x14.7%
GENERAL ELECTRIC CO
US_GE
USIndustrials+6% 0.5%2.8%-9.3% ▲6.8%32.9x39.4x18.9x53.1%
Marvell Technology, Inc.
US_MRVL
USUnited States — large cap (SEC filings)+5% 0.1%2.4%36.5% ▲26.4%72.3x72.9x13.5x6.7%
Meta Platforms, Inc.
US_META
USCommunication services+5%0.3%5.3%28.0%1.4%13.7x22.9x7.2x25.1%
HOME DEPOT, INC.
US_HD
USConsumer discretionary+4%2.9%3.8%4.8%1.2%15.1x22.8x24.9x98.6%
INTERNATIONAL BUSINESS MACHINES CORP
US_IBM
USTechnology-1% 2.9%1.8%1.1% ▲-0.9%18.0x20.8x6.8x25.7%
AbbVie Inc.
US_ABBV
USHealth care-2% 2.7%4.1%10.2% ▲-5.1%22.2x72.1x-56.0%
VERIZON COMMUNICATIONS INC
US_VZ
USCommunication services-2%5.6%10.3%-0.7%7.0%8.1x13.1x2.0x14.6%
T-Mobile US, Inc.
US_TMUS
USCommunication services-6% 2.2%7.5%7.9% ▲6.8%7.4x19.4x3.5x23.1%
PROCTER & GAMBLE Co
US_PG
USConsumer staples-7%2.9%5.4%1.5%-11.7%15.7x21.2x6.5x22.3%
MCDONALDS CORP
US_MCD
USConsumer discretionary-8%2.9%4.1%3.7%-8.7%16.1x20.7x-123.4%
LAM RESEARCH CORP
US_LRCX
USTechnology-15% 0.3%1.2%-13.0% ▲-28.3%52.3x64.3x39.0x34.7%
Seagate Technology Holdings plc
US_STX
USUnited States — large cap (SEC filings)-15% 0.3%1.7%-11.8% ▲-24.9%58.3x58.4x128.4%
Merck & Co., Inc.
US_MRK
USHealth care-17% 2.2%-1.8%5.1% ▼-101.5%35.4x118.8x7.2x-12.2%
INTEL CORP
US_INTC
USTechnology-28%-0.5%25.4%42.0x4.2x-50.4%
QUALCOMM INC/DE
US_QCOM
USTechnology-47% 2.1%6.6%-4.0% ▲-36.0%15.8x19.6x8.5x9.7%

Earnings analysis

Short take-aways from recent corporate results and commodity trends.

Micron: an 84.6% gross margin and the contracts that promise to end the cycle

MU →

A deep review of Micron Technology (Nasdaq: MU), the only American maker of DRAM and one of just three companies producing it at industrial scale anywhere. Micron has just reported a quarter with no precedent in its history: a gross margin of 84.6%, against a previous record of 61.0% set in 2018. The stock is up elevenfold in two years. What follows is what actually happened, what drove it, how durable the company's competitive position is, and what has to be true for the shares not to be a textbook trap at the top of a cycle.

The full financial history is on our company page.

Investment highlights

A record quarter. Revenue of $41.5bn against $9.3bn a year earlier, a gross margin of 84.6% against a previous record of 61.0%, and $24.67 per share. Fourth quarter guidance is $50bn and $30.73 a share, reported on 30 September.

Price did the work, not volume. DRAM average selling prices rose roughly 260% over the year while bit shipments rose about 20%. Since the autumn of 2024 the price index is up 3.9 times and the volume index by half.

The shortage is structural. On TrendForce estimates DRAM supply falls 1-2% short of demand in 2026, the gap widens in 2027, and meaningful output from new industry capacity does not arrive before 2028. The DRAM market: $619bn in 2026 and $903bn in 2027.

The business model is changing. Multi-year take-or-pay contracts with a price floor deliver, on the company's own account, a gross margin above the peak of any past cycle; $22bn of commitments are already signed, $18bn of it as cash deposits. The other side is a ceiling near the second-quarter 2026 price.

The competitive position is uneven. In DRAM Micron is third at 24%, close behind SK hynix, but in HBM it is third at 18% against SK hynix's 50%. The main structural risk is China's CXMT: share up from 4% to 10% in a year, with the technology gap down to two or three years.

Thirteen straight quarters ahead of its own guidance, the last five above the top of the range. The fourth-quarter outlook is probably conservative too.

Valuation. 23 times trailing-twelve-month earnings, 14 times full fiscal 2026 and 8.3 times annualised fourth-quarter guidance. Net cash of $24bn for the first time in the company's history.

Against its peers. Micron has the fastest growth in the group and shares the top EBITDA margin with SK hynix and TSMC, while its 17.2x multiple is half that of NVIDIA and Broadcom. The Koreans trade at 6.7-8.2x, but adjusted for country (a US median of 20.6x against Korea's 7.9x) that is 17.5-21.4x, so Micron carries no premium to its peers at all.

Our model: a target price of $1,868 and an upside of plus 84% on a conservative memory price, today's volume and a 23.6x multiple. On a more cautious 18.7x it is $1,488 and plus 46%.

The main risks. The contract floor protects the margin percentage, not the amount of profit: back at a 70% margin the multiple becomes 26. And our cycle indicator is at its maximum, after which twelve-month returns have historically been weak.

A quarter without precedent

Micron's third fiscal quarter of 2026 ended on 28 May. Revenue came in at $41.5bn against $9.3bn a year earlier, a 4.5-fold increase. Gross profit was $35.1bn, operating profit $33.3bn (80.4% of revenue) and net profit $28.2bn, or $24.67 per diluted share versus $1.68 a year ago.

For the first nine months of the year revenue reached $79.0bn and net profit $47.3bn.

Guidance for the fourth quarter, which closed at the end of August: revenue of $50bn plus or minus $1bn, gross margin around 86%, earnings of $30.73 per share. The report lands on 30 September. That is the nearest point at which every assumption in this review gets tested.

Micron quarterly revenue and gross margin. Source: company filings with the SEC
Micron quarterly revenue and gross margin. Source: company filings with the SEC

For scale. Gross margin is the share of revenue left after the direct cost of production. For a memory chipmaker it has historically swung from minus 30% at the bottom of a cycle to 55-60% at the top. Micron has visited both edges in three years.

Micron gross margin by quarter. The dashed line is the old record of 61.0% (2018)
Micron gross margin by quarter. The dashed line is the old record of 61.0% (2018)

All of the growth came from price, not from volume

This is the single most important observation in the report, and the company does not hide it. The 10-Q breaks down where the year-on-year sales growth came from:

DRAM (the main memory that accounts for the bulk of the business) - revenue up 343%, of which average selling prices up roughly 260% while bit shipments rose only about 20%

NAND (flash memory used in storage) - revenue up 361%, with prices up around 310% and volumes up by a low double-digit percentage.

Cost of goods sold rose from $5.8bn to $6.4bn over the year, or 10%, while revenue multiplied by 4.5. Micron is selling roughly the same bits it sold a year ago, at 3.5 times the price. That is where the 84.6% comes from: every increment of price drops into gross profit whole.

Index of Micron's DRAM pricing and bit shipments, FQ4'24 = 100
Index of Micron's DRAM pricing and bit shipments, FQ4'24 = 100

The same arithmetic in levels rather than percentages. Micron discloses the change in pricing and shipments in every quarterly filing; chained into an index, those disclosures show that since the autumn of 2024 the DRAM average selling price has risen 3.9 times while bit shipments have risen by half. Essentially all of the revenue growth is the upper line on the chart.

Industry prices tell the same story. On TrendForce estimates, conventional DRAM contract prices rose 45-50% in the fourth quarter of 2025, 93-98% in the first quarter of 2026 and 58-63% in the second. On the spot market on 7 September 2026 a DDR5 16Gb die was $54.3 and a DDR4 16Gb die $93.3; over the year, on the DRAMeXchange spot board, they are up roughly 480% and 690% respectively.

One detail deserves its own sentence: legacy DDR4 now costs almost twice as much as newer DDR5. Manufacturers are winding down older memory types and converting lines to DDR5 and HBM, while the equipment that takes DDR4 has not gone anywhere. It is hard to think of a starker illustration of the shortage.

The practical conclusion. This is not a story about operational improvement or a new product that displaced competitors. It is a price shock in an industry where Micron happens to be one of three recipients of the rent. So the thing to assess is not execution quality but the durability of the shortage itself.

Revenue and operating margin by business unit: a year ago and now
Revenue and operating margin by business unit: a year ago and now

The breadth of the move shows up in the segments. All four business units now run operating margins above 75%, including automotive and embedded, which has nothing to do with artificial intelligence. When server memory and memory for household appliances earn equally well, that is a sign of shortage, not of product advantage.

The shortage is real, and there is no quick fix

An independent read on the industry from research house TrendForce (July-August 2026): the DRAM sufficiency ratio, which measures how far supply covers demand, stands at minus 1-2% in 2026, and the gap is expected to widen in 2027. The DRAM market is put at $618.7bn in 2026, a fourfold increase, and $903.3bn in 2027, up 46%. The whole memory market is forecast to exceed $1.28tn in 2027.

DRAM market revenue by quarter and by year, with the forecast. Source: TrendForce
DRAM market revenue by quarter and by year, with the forecast. Source: TrendForce

In money the picture looks like this. Quarterly revenue for the whole DRAM industry: $41.4bn in the third quarter of 2025, $97.0bn in the first quarter of 2026 and $154.7bn in the second - up 3.7 times in three quarters. By year: $90.7bn in 2024, around $154bn in 2025, a forecast $618.7bn for 2026 and $903.3bn for 2027. On TrendForce's numbers the DRAM market will therefore be roughly ten times its 2024 size within three years.

The flash forecast is more modest: $270.6bn in 2026 and $379.4bn in 2027. Together those give the $889bn memory market of 2026 and the $1.28tn-plus of 2027.

The reason the shortage cannot clear inside a year is arithmetic. HBM is high-bandwidth memory, the kind stacked next to AI accelerators. In 2026 it will account for only 9% of DRAM bits but consume 22% of the industry's silicon wafers; by the end of 2027 that becomes 13% of bits and 30% of wafers. HBM is assembled in multi-layer stacks, and each usable bit takes several times more silicon area than a conventional memory module. Every HBM bit a manufacturer sells is subtracted from the supply of ordinary memory. That is why prices have risen for server and consumer modules that have no direct connection to AI at all.

New plants do not help inside the forecast horizon: on TrendForce's estimate, meaningful output from new capacity will not arrive before 2028. Micron's own record shows the timescale. Ground was broken on the Boise, Idaho fab in September 2022, construction started in October 2023, and the first DRAM wafers are expected in mid-2027. Five years from shovel to product.

The real news is not the margin, it is the contracts with a price floor

In the third and fourth quarters Micron began signing what it calls strategic customer agreements. The terms are set out in the 10-Q, and they change the shape of the business more than the record margin does:

– they are take-or-pay, meaning the customer either lifts the agreed volume or pays for it anyway; volume commitments are locked in for several years

– for most agreements the price is either fixed or bounded by a floor and a ceiling

for the largest agreements the ceiling approximates the market price of the second calendar quarter of 2026, and the floor holds for the whole term

– in the company's own words, gross margins under these contracts even at floor pricing will run well above the peak quarterly margin of any past cycle, which is to say above 61%

– a minority of the agreements carry no price bands and follow the market

Micron expects $22bn of deposits and related financial commitments from agreements concluded so far, of which roughly $18bn arrives as cash.

What this means in substance. A memory maker has always traded cheaply on peak earnings precisely because peak earnings said nothing about next year. If the contracts work as described, a significant part of revenue for several years stops being a function of the spot price and starts to resemble contracted revenue with a guaranteed minimum margin. The $18bn of deposits also amounts to free financing for the build-out: customers are prepaying for the very capacity they have signed up for.

The other side sits in the same paragraph. A ceiling near the second-quarter 2026 level means further increases in spot prices will largely bypass Micron. The company has traded the upper tail of the distribution for the lower one.

That is the most plausible explanation for the share price. From a high of $1,213 on 25 June the stock has drifted back to $1,017, down 16%, even though the reported numbers have only improved since. The market has worked out that the option on higher prices is now closed.

Two years: Micron, the SOXX semiconductor index and the S&P 500, log scale
Two years: Micron, the SOXX semiconductor index and the S&P 500, log scale

Strong in DRAM, a distant third in HBM

Two markets are often conflated here and need separating. Conventional DRAM is a three-way oligopoly in which Micron is firmly established. HBM is a narrower and far more profitable segment, and the line-up there is different.

Revenue shares in the second quarter of 2026. Source: Counterpoint Research
Revenue shares in the second quarter of 2026. Source: Counterpoint Research

On Counterpoint Research data for the second quarter of 2026, in DRAM Samsung holds 38%, SK hynix 25% and Micron 24%, with China's CXMT at 10% and Taiwan's Nanya at 2%. Micron sits third, close behind SK hynix, and Counterpoint notes separately that Micron's DRAM revenue has risen fivefold in a year and that the company could take second place.

In HBM the picture is worse: SK hynix 50%, Samsung 33%, Micron 18%. SK hynix has lost 14 percentage points in that segment over the year, down from 64%, and Samsung was first into volume production of HBM4 in February 2026. In the most valuable part of the market Micron is the one catching up, and the competition there is real rather than nominal.

What is genuinely solid:

Technology. HBM4 on the 1-beta process is already shipping in volume to the lead customer, with qualification samples out to several end customers; HBM4E on the next 1-gamma process is scheduled for volume production in 2027. Alongside that: 256GB DDR5 modules, LP5X SOCAMM2 in high-volume production, PCIe Gen6 drives and a 245TB SSD.

The barrier to entry is money and time. Five years from groundbreaking to first wafer, and $27bn of capital expenditure in fiscal 2026 alone. That explains why the three incumbents are in no hurry to fight for share: Micron states plainly in its filing that its objective is to maintain stable bit share, not to grow it.

Less dependence on a single buyer. The largest customer accounted for 10% of revenue in the first nine months of 2026, down from 16% a year earlier.

Government support. Up to $6.4bn in grants under the US CHIPS Act, a 35% investment tax credit on US manufacturing investment, and a non-binding term sheet with New York State worth up to $5.5bn. In a world where memory has become a strategic commodity, the only American DRAM producer gets an extra layer of protection.

What could break the story

China. The main threat to the structure of the market is CXMT. On Counterpoint data its share of DRAM revenue has gone from 4% to 10% in a year, with revenue up 716%, and for the first time the combined share of the top three has fallen below 90%. The technology gap, once put at five years or more, has narrowed to two or three. In July 2026 the company raised $8.6bn in an IPO and is weighing a sixth fab; capacity of roughly 300,000 wafers a month is planned to reach 550,000-600,000 by 2028, comparable to SK hynix. For reference, Micron's own capacity at the end of 2026 is estimated at around 385,000 wafers a month (SemiAnalysis). CXMT plans volume production of HBM3E as soon as this year.

NAND is diverging from DRAM. TrendForce expects flash supply to turn loose in the second half of 2027 as new capacity comes online while consumer electronics demand stays weak. Micron's NAND prices are up 310% over the year, and that is the part of the business where the turn arrives first.

Micron's own capacity wave. The company is simultaneously building a second Idaho fab (output late 2028), a site in Clay, New York (supply from 2030), HBM packaging in Singapore from the first half of 2027 plus an additional fab in the second half of 2028, and in Taiwan the Tongluo fab bought from Powerchip for $1.8bn with shipments from mid-2027. The competitors are doing the same. Discipline in the memory industry has always held right up to the point where everyone starts building at once.

A competitor's inventory. Samsung's inventory has risen from 87 to 124 days of cost of sales in three quarters. Micron and SK hynix are stable around 122-123 days. On its own this is not a signal that the cycle has turned, since Samsung may be building for contracted shipments. But it is usually the first metric to break before prices do.

Inventory in days of cost of sales at the three memory makers
Inventory in days of cost of sales at the three memory makers

Tax. The effective rate has risen from 11.1% to 15.0% because of the Pillar Two global minimum, which in Singapore has offset the incentives Micron used to enjoy.

Our cycle indicator is pinned at its maximum, which historically is a bad sign a year out

We maintain our own composite indicator of the memory cycle. It pulls in monthly revenue from Taiwan's Nanya and Winbond, DRAM spot prices, and the trend in margins, inventory and capital spending at Micron and SK hynix; each component scores plus one, zero or minus one. The composite currently reads plus 5 out of 5 active signals, the maximum. Nanya's three-month revenue is up 50% on the prior three months and sevenfold year on year, Micron's margin gained 10 percentage points in a quarter, capex to revenue sits below its three-year median, and SK hynix's inventory days fell by 11.

A backtest over 2006-2026 produces an uncomfortable result. With a positive composite, the following six months are genuinely better than average for Micron shares: a median of plus 11.6% against plus 5.3% after negative readings. But over twelve months the sign flips: a median of plus 3.8% after strong readings against plus 18.7% after weak ones.

Put plainly, strong fundamental readings confirm a turn that has already happened rather than predict the next one. A maximum composite describes the present; it is not a forecast.

Thirteen straight quarters ahead of its own guidance

Micron publishes an outlook for the next quarter in every release: revenue, gross margin and earnings per share. The following release states the actual. Checked across thirteen consecutive quarters the record has no exceptions: revenue has never come in below the midpoint of the guided range.

Company guidance against the actual, US GAAP. Source: Micron earnings releases
Company guidance against the actual, US GAAP. Source: Micron earnings releases

What matters more is how the size of the beat has changed. On revenue: plus 0.1% in the first quarter of fiscal 2025, plus 5.7% six months later, plus 9.1% in the first quarter of 2026, then plus 27.6% and plus 23.8% in the last two. On earnings per share the gap is wider still: plus 8% at the start of the run against plus 47% and plus 31% in the last two quarters. In each of the last five quarters the actual came in above not just the midpoint but the top of the guided range.

The mechanism is obvious, and it is also what limits the conclusion. Micron builds its outlook on the prices it can see when it reports, and in a shortage prices keep rising inside the quarter. This is not management being cautious, it is a market moving faster than anyone can forecast it. The same mechanism runs in reverse: at the turn of the cycle guidance will be systematically too high.

Two conclusions follow. First, the fourth-quarter guidance of $50bn and $30.73 a share is probably conservative. If the gap of the last two quarters repeats, 30 September brings revenue near $60bn and earnings around $40 a share, which is about 6.5 times earnings at the current price rather than 8.3.

The second conclusion is the cautious one, and it follows from the same contracts. Agreements with a price ceiling are precisely what should narrow this gap: if a large share of volume sells at a pre-agreed price, spot increases inside the quarter stop showing up in the result. Micron says explicitly that the contracts give it better visibility. Better visibility also means beats of this size are over.

Valuation: 8 or 23 times earnings, and the gap rests on a single assumption

Key figures for Micron as of 4 September 2026
Key figures for Micron as of 4 September 2026

At $1,016.59 a share Micron is capitalised at roughly $1.15tn. For the first time in its history the company holds a net cash position: $30.1bn of cash and investments against $5.7bn of debt, cut from $14.6bn over nine months. Enterprise value is about $1.12tn.

From there everything depends on which earnings you treat as normal:

– on the last twelve months of profit ($50.5bn) the stock trades at 23.1 times earnings and 16.4 times EBITDA; adjusting for stock-based compensation ($954m over nine months), EV/EBITDAC is about 16.8

– on full fiscal 2026 earnings including fourth-quarter guidance ($72.13 per share) the multiple is 14.1

– on annualised fourth-quarter guided earnings it is 8.3 times, with EV/EBITDA on the annualised latest reported quarter at about 7.9.

Twenty-three times earnings is expensive for a cyclical company. Eight is cheap even for a stable one. The distance between those two numbers is the whole argument about Micron.

And this is where most write-ups fall into a trap. The contract floor protects the margin percentage, not the amount of profit. A margin is a ratio. If the price falls to the lower band, revenue falls with it while the cost of producing the same volume stays where it is. Working from the latest quarter, where cost of goods sold was $6.4bn:

– at today's 84.6% margin, gross profit is $35.1bn a quarter, which is about ten times earnings at the current share price

– at a 75% margin, revenue on the same volume falls to $25.6bn and gross profit to $19.2bn, and the multiple rises to roughly 20

– at 70%: $21.3bn of revenue, $14.9bn of gross profit, about 26 times earnings

– at 61%, the previous peak of the cycle: $16.4bn of revenue, $10.0bn of gross profit and more than 40 times earnings.

Only volume growth softens that arithmetic. At $27bn of capital spending a year, shipments by 2028 could be 50-60% above today's, which would put the same scenarios at roughly 12 to 25 times earnings instead of 20 to 42. The conclusion holds either way: 8.3 is a multiple on peak pricing, and the floor limits how far profit falls rather than holding it where it is.

So the argument about Micron is not whether the margin stays above 60%. It is two other questions: how high the floor sits in absolute prices, and how much volume it covers. The company has disclosed neither.

Capital returned to shareholders is meanwhile token. The dividend is $0.15 a quarter, a yield of 0.06%, and $7.84bn of the authorised $10bn buyback has been used over the life of the programme. The money is going into construction: $27bn of capex in fiscal 2026. An investor in Micron is paying not for distributions but for a claim on future capacity.

Against its peers: the fastest growth, cheaper than the AI names

Micron sits usefully against three groups at once: the other memory makers, the foundries, and the designers of AI silicon. Growth below is the latest reported quarter year on year; margin and multiple are trailing twelve months, so both sides of EV/EBITDA use the same window.

Growth, margin and multiple across the group
Growth, margin and multiple across the group

Micron, US - $90bn of revenue over the year, growth of plus 346%, an EBITDA margin of 76%, EV/EBITDA 17.2x

SK hynix, Korea - $140bn, plus 257%, margin 77%, 8.2x

Samsung, Korea - $360bn, plus 130%, margin 48%, 6.7x

NVIDIA, US - $253bn, plus 85%, margin 65%, 34.3x

Broadcom, US - $89bn, plus 85%, margin 63%, 39.3x

Western Digital, US - $13bn, plus 44%, margin 39%, 29.6x

TSMC, Taiwan - $141bn, plus 36%, margin 76%, 20.1x.

The first thing that stands out: Micron has the fastest growth in the entire group and shares the top EBITDA margin with SK hynix and TSMC. Yet its multiple is half that of NVIDIA and Broadcom, and below TSMC's, a company growing ten times more slowly.

The second stands out even more. The Korean memory makers, on almost identical economics, trade at 6.7 and 8.2 times EBITDA, two to three times cheaper than Micron. SK hynix has the higher margin of the two and grows only slightly more slowly. On the face of it Micron carries a large premium to its closest peers.

But this is where the country of listing enters, and it is worth measuring rather than merely mentioning. Across our own coverage, on identical method, the median EV/EBITDA of 116 US companies is 20.6x and of 22 Korean companies 7.9x, a gap of 2.6 times - and that is about the market, not about memory.

Lift the Koreans onto US multiples and the picture inverts: SK hynix would trade at 21.4 times EBITDA, Samsung at 17.5, and Micron trades at 17.2. There is no premium to its closest peers at all; Micron is marginally cheaper, and the visible gap is the Korean discount. TSMC corroborates it from the other side: a Taiwanese company listed in the US through depositary receipts, trading at 20.1x, right on the US median.

Which leads into the next section. The argument about Micron's multiple is an argument about which group it belongs to: NVIDIA and Broadcom at 34-39x, or the country-adjusted Koreans at 17-21x. The case for the first is the HBM share and the data-centre contracts; for the second, the same cyclicality and essentially the same commodity. Either way the 23.6x we take as the target sits inside the range rather than above it.

Our model puts Micron at plus 84%

Economically Micron is a producer of a commodity with an exchange-quoted price, so it is worth running it through the same model we use for commodity producers. Three steps. First, take the latest reported quarter annualised, which is today's actual volume and cost, and reprice the revenue as if the price stood at a normalised level. Second, the conservative price is the midpoint between today's and the three-year average, and by the rule of the model conservative EBITDA can never exceed EBITDA at today's price. Third, multiply by the company's own historical EV/EBITDA, add net cash and compare with the market capitalisation.

The price input is our DRAM index built from Micron's disclosures, extended three years back. Today's level is 658 and the three-year average is 226, which is only 34% of the current price. The conservative case takes the midpoint, 442, implying a price decline of a third from here.

Micron through the model we use for commodity producers. Enhanced Investments calculation
Micron through the model we use for commodity producers. Enhanced Investments calculation

Annualised EBITDA comes out as follows: $143bn at today's price, only $34bn at the three-year average, and $88bn on the conservative basis. Actual EBITDA over the last twelve months was $68bn, because three of those four quarters ran at both lower prices and lower volumes.

Then the multiple. The target is the 75th percentile of Micron's own EV/EBITDA over three years, 23.6x - what the market itself has paid for this company in the upper part of its range over that period. It trades at 17.2x today.

That figure carries a distortion worth naming up front. Of the roughly 250 days on which the multiple stood at 23.6x or above, about 80% fall between September 2023 and July 2024, when the company was only emerging from a loss and the denominator was tiny: monthly medians in that stretch reached 40-80x. In every window that excludes that tail the percentile settles at around 18-19x: 18.7x over three years ex-trough, 19.1x over the last twelve months, 18.2x over two years and 18.1x over six.

The result: $88bn of EBITDA at 23.6x gives a target enterprise value of $2.08tn, plus $24bn of net cash, so $2.11tn against a $1.15tn market cap. A target price of $1,868 a share against today's $1,017, an upside of plus 84%. On the more cautious 18.7x it is $1,488 and plus 46%.

It is worth looking from the other side too. To justify today's price the market only has to pay 12.7 times normalised EBITDA. That is below the company's current 17.2x and below every percentile listed above, though still above its six-year median of 10.9x.

Three caveats, without which the number misleads. First, the three-year window contains the deepest trough in the industry's history - in 2023 Micron ran a negative gross margin, which drags the normalised price down further than an ordinary cycle deserves. Second, the model holds volume and cost at today's level while the company is building $27bn of capacity a year, so shipments in 2028 will be materially higher. Third, and most important: take-or-pay contracts with a price floor are precisely the argument that the price will not revert to the three-year average.

The main conclusion here deserves to be stated plainly. The memory price in this calculation is already taken conservatively, and all of the remaining uncertainty sits in the multiple. The upper part of the company's own historical range gives plus 84%, the stable 18-19x gives about plus 46%, and the six-year median gives minus 14%. A wide spread, but what matters is that it is set by what the market will pay for normalised earnings, not by a forecast of the DRAM price.

Volume is growing too, and by 2028 the model turns positive

It matters that the calculation above is not about reselling the same bits at a higher price. Micron's shipments are growing: the bit-shipment index has risen from 100 at the end of fiscal 2023 to 173, up 73%, of which plus 21% came in the last year alone. Price simply moved six times faster over the same period, which is why it drives almost the whole result.

Price and volume separately, and the upside in each combination. Enhanced Investments calculation
Price and volume separately, and the upside in each combination. Enhanced Investments calculation

Next, add what the $27bn of annual capital spending is actually for. Take volume up 30% by 2028, two years at 14% a year, which is half the pace Micron has actually delivered over the past three years. Cost of goods in this case scales one-for-one with bits, with no improvement in cost per bit, and depreciation rises 40% for the new fabs.

The full picture across six combinations of price and volume, at the 23.6x target multiple:

three-year average price: minus 28% on today's volume and minus 2% on the 2028 volume

conservative midpoint: plus 84% today and plus 143% by 2028

today's price: plus 196% now and plus 288% by 2028.

It is important not to get carried away here. At that multiple five of the six cases are positive, which means the model has stopped being a stress test and is describing a base case. The bottom row is the more useful one: even with prices back at the plain three-year average and no volume growth at all, the loss is 28%, and with the 2028 capacity it is roughly zero. That is the real boundary of the risk.

The same sum in reverse: for today's price to be fair at the target multiple, DRAM prices would have to fall 57% - almost to the three-year average, though still not quite to it.

So the answer to whether there is upside: on the company's own historical multiple, yes, and a substantial one. It rests on two assumptions: that the price does not go below the midpoint of today and the three-year average, and that the market will pay for Micron what it has paid on average over the past three years. The first is underpinned by the floor-price contracts; the second is underpinned by nothing, and that is where most of the risk sits.

An earnings-quality check: receivables tripled, but not in days

With growth like this, the first thing to check is whether the profit has been manufactured out of shipments that will never be paid for. Micron's receivables tripled, from $9.3bn to $31.0bn. But measured in days of revenue that is 68 days against 75 a year earlier, so collection has improved, not deteriorated. Inventory is steady at $8.6bn, or 122 days of cost of sales.

Cash flow corroborates the profit. Over nine months operating cash flow was $45.7bn against net profit of $47.3bn, capital expenditure was $19.6bn and free cash flow roughly $26bn. On the numbers there is nothing to fault in earnings quality.

Conclusion

Micron today is not a bet on the memory cycle, nor a pure bet on artificial intelligence. It is a bet that multi-year contracts with a price floor will survive the next downturn. Everything else in the story has already happened: prices rose, margins hit a record, the stock went up elevenfold in two years, and the contractual ceiling has been set.

For: the DRAM shortage is independently confirmed and structurally unfixable before 2028; the contract floor is, on the company's own account, above any previous peak; net cash for the first time in years; on current earnings the valuation is modest at 8 to 14 times; the company has beaten its own guidance for thirteen straight quarters and the fourth-quarter outlook is probably conservative too; volume is growing and not just price; on a conservative price, today's volume and the company's own historical 23.6x the model gives plus 84%, and plus 46% on a more cautious 18-19x; and earnings quality survives inspection.

Against: all of the growth came from price rather than volume; the contract floor protects the margin percentage rather than the amount of profit, and a return to a 70% margin puts the multiple at 26; the model's upside rests on the multiple, and on the company's six-year median it is negative; Micron is third in HBM with 18%; CXMT has multiplied its share by 2.5 in a year and closed the technology gap to two or three years; NAND is forecast to turn as early as the second half of 2027; and our cycle indicator is at its maximum, after which twelve month returns have historically been weak.

What to watch. The main event is the fourth-quarter report on 30 September, and with it any disclosure of how much 2027-2028 volume is under contract and where the floor sits. Those are the numbers that settle the central argument. After that come Samsung's and SK hynix's inventories in the next quarterly filings, and DRAM spot prices. Until those start falling, talk of a turn is premature.

The full Micron page with reporting history and multiples is on the Enhanced Investments portal. Company deep dives, weekly reviews and investment ideas are published in our Telegram channel Enhanced Investments.

AI capex supercycle: semis and power suppliers outpace a fading consumer patch

This earnings season is defined by one dominant divergence: the AI infrastructure buildout is minting growth rates that look like typos, while the rest of the economy — from telecoms to consumer cyclicals — is grinding out mid-single-digit gains at best. Median revenue growth for tech hit +24.8%, nearly five times the pace of consumer staples (+6.6%) and consumer discretionary (+5.4%). The gap is even starker at the company level: Micron grew revenue +345.7% year over year, while AT&T managed just +2.3% and Verizon actually shrank -0.7%. This is not a broad recovery; it's a targeted capex boom with clear winners and clear losers.

Revenue growth by industry (median YoY)

United States / Canada — oil &…62United States — oil & gas expl…33United States — large cap (SEC…28Technology25Industrials14Health care9.5Communication services7.9Consumer staples6.6Consumer discretionary5.4062
median revenue YoY, %

Memory and networking are the new oil wells

The standout growth story is in semiconductors and adjacent hardware, where demand for AI data centers is creating unprecedented tailwinds. Micron's revenue explosion of +345.7% is the headline, but it's not alone: Broadcom grew +85.5%, NVIDIA +85.2%, and AMD +50.1%. Even more telling, the EBITDA growth at these names is accelerating faster than revenue — Micron's EBITDA swung from negative to positive (n/m), Broadcom's net profit jumped +216.1%, and NVIDIA's EBITDA rose +145.1%. This is operating leverage on steroids, driven by pricing power and capacity constraints.

The AI wave is also lifting the broader ecosystem: Arista Networks grew revenue +37.7% with 3-year CAGR of +27.1%, and Credo Technology, a niche connectivity player, saw revenue surge +114.7% with EBITDA up +95.3%. Even older-line tech giants are benefiting — Analog Devices grew +39.6%, and Texas Instruments +22.8%, both rebounding from cyclical lows. The message: this is not just a chip story; it's a whole supply chain re-rating.

Natural gas drillers are the season's biggest losers

While oil producers are riding high on +32.6% median revenue growth, their natural gas peers are in a deep freeze. CNX Resources saw revenue collapse -35.7%, with EBITDA down -43.9% and net profit -53.1%. EQT Corporation wasn't far behind, with revenue -29.2% and net profit -73.0%. Even Comstock Resources, classified as oil & gas, suffered a -24.9% revenue drop. The culprit is plain: weak gas prices are crushing margins, and the P/E of 5.9x on CNX looks like a value trap, not an opportunity, when earnings are falling off a cliff.

The plot twist: Intel's revenue rebound masks a profit disaster

Here's the surprise: Intel grew revenue +25.4% year over year — its best performance in years — yet net profit plunged -278.1% and EBITDA is n/m (negative). That's a company spending heavily to compete in AI chips, but the market is pricing it at 42.3x EV/EBITDA, a premium that assumes the losses are temporary. Compare that to Qualcomm, which saw revenue -4.0% and net profit -24.9%, yet trades at just 19.3x P/E. The twist: Intel's top line is accelerating, but the bottom line is deteriorating — a classic sign of a company buying growth with no pricing power.

Cheap for a reason: oil majors offer growth at single-digit multiples

For value investors, the oil patch is the place to be. SM Energy grew revenue +215.3% and trades at just 8.7x P/E and 2.4x EV/EBITDA. Chord Energy is similarly cheap at 9.5x P/E with revenue +84.0%. Even the more diversified names like APA Corporation (P/E 9.0x) and Devon Energy (P/E 11.4x) offer growth rates in the double digits. The market is clearly skeptical that these growth rates are sustainable, but at these multiples, you're getting paid to wait. In contrast, Palantir trades at 138.9x P/E with revenue growth of +92.8% — that's priced for perfection, and any hiccup will be brutal.

Income is scarce, but these yields stand out

In a world of low yields, a few names offer genuine income. AT&T, despite its sluggish growth, yields around 5% (based on a P/E of 8.3x and typical payout), making it a bond proxy. Verizon, with a P/E of 13.0x, yields even more — roughly 6.5% — but its revenue decline of -0.7% is a warning sign. For a mix of growth and income, Philip Morris International yields about 4.5% (P/E 26.2x) and grew revenue +10.4%. None of these are exciting, but for yield-hungry investors, they're the best of a thin bunch.

Looking ahead, the 3-year revenue CAGRs tell you who has durable momentum: NVIDIA at +100.0%, Super Micro at +61.7%, and Robinhood at +48.8% are compounding at extraordinary rates. But the real question is whether the AI capex cycle can sustain this pace. Watch for signs of digestion — if memory prices soften or hyperscalers pause, the entire chain from Micron to Vertiv will feel it. For now, the bulls are in control, but the gap between AI winners and everyone else has never been wider.

Players: growth & yield (no absolute levels)

CompanyIndustryRevenue YoYEBITDA YoYNet profit YoYP/E
AMAZON COM INC (Q2)Consumer discretionary+19.6%+37.9%+244.9%20.6x
Walmart Inc. (Q2)Consumer staples+4.9%+23.5%-9.4%38.6x
Alphabet Inc. (Q2)Communication services+24.2%+32.0%+297.9%17.0x
UNITEDHEALTH GROUP INC (Q2)Health care+0.4%+44.9%+61.0%25.5x
Apple Inc. (Q3)Technology+16.4%+25.7%+27.1%36.3x
MICROSOFT CORP (Q4)Technology+17.7%+32.7%+31.3%27.7x
NVIDIA CORP (Q1)Technology+85.2%+145.1%+210.6%35.1x
COSTCO WHOLESALE CORP /NEW (Q3)Consumer staples+11.6%+15.7%+15.2%49.2x
Meta Platforms, Inc. (Q2)Communication services+28.0%+4.5%-13.6%23.0x
JPM (Q2)+27.7%+57.8%+41.2%n/m
Dell Technologies Inc. (Q1)United States — large cap (SEC filings)+87.5%+131.9%+256.3%40.5x
HOME DEPOT, INC. (Q1)Consumer discretionary+4.8%+1.4%-4.2%22.9x
MICRON TECHNOLOGY INC (Q3)Technology+345.7%n/mn/m22.7x
VERIZON COMMUNICATIONS INC (Q2)Communication services-0.7%+7.0%-23.3%13.0x

PepsiCo at six-year lows: a Dividend King de-rated from 31x to 18x earnings, with Elliott inside

PEP →

A look at PepsiCo (Nasdaq: PEP) on the fresh Q2 2026 report. The prompt was 'a good report, but the stock is at six-year lows' - we checked both halves against primary data. Short version: the report is normal rather than good, the lows are real, and the heart of the case is that the market now pays almost half as much for the same earnings (multiple compression from 31x to 18x) while the business kept growing all along - and a large activist shareholder with a change agenda is already inside.

The price is back to 2019: seven years of business growth, none for the stock

$135 per share is summer-2019 territory; in seven years the price was lower only in the covid crash of March 2020 ($104). Formally 'six-year lows' is almost exact: excluding three weeks of 2020 panic, the current price is the bottom of the entire seven-year range. Over those same seven years revenue grew from ~$67bn to $94bn and the dividend was raised every single year.

Seven years of PepsiCo's price: back to 2019
Seven years of PepsiCo's price: back to 2019

The Q2 2026 report: 'it did not get worse' is what the market called good

The quarter's facts: revenue $24.18bn (+6.4%) - above expectations; organic growth +2.4%; adjusted EPS $2.20 - 1-3 cents below consensus; full-year guidance confirmed (organic +2-4%, core constant-currency EPS +4-6%). Geography is two-speed: North America is weak (snacks losing pricing power, sluggish volumes) while international - Asia, EMEA, the beverage franchise - grows volumes and pulls the group. In other words, after two years of downgrades a 'good report' literally means 'guidance confirmed, nothing broke' - the expectations bar is on the floor, which is information in itself.

Business vs stock: the entire decline is multiple compression

The decomposition is simple. Five-year revenue: $79.5bn to $94bn (+18%). Dividend per share: $4.25 to $5.75 (+35%), the 54th consecutive annual increase - Dividend King status. Meanwhile the multiple compressed from 31x earnings to 17.7x - against its own five-year norm of 24-28x. All of the stock's negative return is de-rating, not business degradation. The 4.3% dividend yield is the highest in the company's modern history.

Revenue and dividend: growth without pauses
Revenue and dividend: growth without pauses
De-rating from 31x to 18x and a record dividend yield
De-rating from 31x to 18x and a record dividend yield

What GLP-1 is and why it made the stock cheaper

GLP-1 is a class of weight-loss and diabetes drugs (best known: Ozempic, Wegovy, Mounjaro - the 'weight-loss injections'). They suppress appetite, and people taking them snack noticeably less - and snacking, Frito-Lay, is the most profitable part of PepsiCo's business. Hence the market's main fear: that falling US snack volumes are not the temporary belt-tightening of an inflation-weary consumer but an irreversible change of habits.

What independent data say. Consumer-purchase researcher Circana (checkout scanner data - actual sales, not surveys): someone in 23% of US households already takes a GLP-1 drug, and such households buy 10.1% less salty snacks and 8% less sweets; by 2030 households with a GLP-1 user may account for up to 35% of US food and beverage sales. Simple arithmetic: 23% of households x minus 10% on snacks is roughly minus 2-2.5% for total market volumes - noticeable, but not 'the end of snacks'. Meanwhile forecasts for the global salty-snacks market remain positive: +5.4% a year to 2030 (Wissen Research; other agencies put it at 4.7-6%) - driven by international markets, where PepsiCo is doing well. So the pessimists have two arguments - cyclical (the US consumer economising after inflation) and structural (GLP-1) - and so far the facts point more to a cyclical character of the decline: volumes are falling precisely in expensive US snacks while international markets and beverages grow. But only a turn in US volumes can prove that to the market conclusively - and that is what everyone is waiting for.

Elliott with $4bn inside: the catalyst is already working

Since late 2025 Elliott Management holds a ~$4bn position with a public plan: focus the beverage portfolio, optimise bottlers, review the North America supply chain, cut costs aggressively. Management has already announced an NA logistics review and a cost programme. Seven months in, the market wants proof - every next quarter becomes a turnaround checkpoint. An activist of this scale inside a Dividend King is a rare configuration: downside protected by the dividend, upside driven by the activist's plan.

Forecasts: consensus target $169 vs a $135 price

The median target of twelve analysts is $169 (+25%), but the spread is honestly wide: Citi cut to $145 after the report (and the rating to Neutral), Barclays raised to $144; the average rating is Hold. Translated from analyst-speak: 'the business is worth more, but buying before the volume turn is scary'. The company's own 2026 guidance is confirmed: organic +2-4%, core EPS +4-6% in constant currency.

Estimated upside: three scenarios over three years

From $135 with forward earnings of ~$8.3 per share (fwd P/E ~16.3). Base: EPS +5%/yr, exit P/E 19 - +48% total return, IRR ~14%/yr (of which ~13pp from dividends). Bull: a volume turn plus the Elliott programme, EPS +8%/yr, return to P/E 22 - +83%, IRR ~22%. Bear: GLP-1 proves structural, EPS flat, de-rating to 14x - roughly zero over three years: the dividend fully offsets the price decline. Probability-weighted (40/30/30) - roughly 12-14%/yr expected dollar return with rare asymmetry: the worst case is ~0, not a loss.

3-year total return scenarios from $135
3-year total return scenarios from $135

Risks

— GLP-1 may prove structural. Then the bear case is not a tail but the base: US snack volumes never return and 14-16x becomes the new normal forever.

— A long stretch of US consumer weakness. Even without GLP-1 the volume turn may take years; every quarter without it risks new downgrades.

— Rates. A 4.3% dividend against ~4%+ on Treasuries is a minimal premium; if the Fed goes higher, the dividend support for the price weakens.

— A 78% payout. Room to grow the dividend faster than earnings is nearly exhausted - payout growth will be slow until EPS turns.

— The activist may leave. If Elliott sees no progress and sells, part of the catalyst premium leaves with it.

Prepared by Enhanced Investments from PepsiCo filings (Q2 2026 press release, SEC 8-K), Nasdaq data and consensus forecasts; July 2026. Not individual investment advice.

13 investment ideas across frontier markets, commodities and US leaders - July 2026

IDEAS →

Thirteen ideas from our coverage across frontier markets, commodities and US large caps. Each was produced by one of five live engines (EM bank value with monthly regulatory data, EM compounders, dividend+catalyst, commodity spot mean-reversion, US Leaders GARP), screened across ~500 issuers and verified against primary filings. Currency math is a first-class criterion: a 12% dividend behind a 13%/yr hedge is worth less than 9% behind a 2.8% one.

The ideas: profitability vs price (bubble = dividend yield)
The ideas: profitability vs price (bubble = dividend yield)
Hedging cost per currency
Hedging cost per currency

Live track records of the two systematic books contributing ideas: US Leaders +274% since Aug 2019 (CAGR 21%, Sharpe 1.0); Global Commodities +137% since May 2020 (CAGR 15%). The commodity engine's latest published call - PBF at $42 on June 25 - is +36%.

US Leaders, live equity curve
US Leaders, live equity curve
Global Commodities, live equity curve
Global Commodities, live equity curve

The numbers layer: valuation vs history and an indicative IRR sketch

Is each name cheap against ITS OWN history, and what annual return does the position imply if the multiple drifts back to the 5-year median while the business grows and pays out? Charts below; per-name assumptions in the cards. Growth assumptions are deliberately conservative vs recent prints; CPIN capped at 15x; VLO on forward earnings; MBRF and KEGOC excluded as not meaningful.

Current P/E vs own 5-year median (label = premium/discount)
Current P/E vs own 5-year median (label = premium/discount)
Indicative 3y IRR = dividend + growth + re-rating
Indicative 3y IRR = dividend + growth + re-rating

Part I. EM bank value

1. Bank Mandiri (IDX: BMRI; ADR PPERY) - the flagship

Indonesia's #2 bank: wholesale-led franchise, 71.6% CASA funding, ROE 20.4% in Q1'26, monthly regulatory data showing acceleration. Expected hedged USD return ~15-16%/yr before re-rating. The Q1 consolidated 'asset shrinkage' is the BSI deconsolidation, not the business. Risks: Danantara governance, directed lending, NIM pressure.

2. Bank Rakyat (IDX: BBRI; ADR BKRKY) - the higher-yield pair

The world's largest microlender (65m borrowers). 2025 was the clean-up year; the cycle is turning. With Mandiri - a sector bet at ~5x earnings with double-digit dividends. Risk: BBRI carries most of the $12bn village-cooperative programme.

3. Banorte (BMV: GFNORTEO) - the dividend machine with direct access

Mexico's #2 financial group: a durable ~10% peso cash yield from a franchise that survived every Mexican cycle since 1899; nearshoring optionality is free. Risks: Banxico cuts, US-Mexico politics.

Part II. EM compounders

4. Kaspi.kz (Nasdaq: KSPI) - quality growth at a value price

Kazakhstan's payments+marketplace+fintech monopoly funding a second act in Turkey (Hepsiburada) from its own cash flow. If Turkey works - a second engine; if not, the core justifies the price. Risks: tenge, fee regulation, Turkish execution.

5. Charoen Pokphand Indonesia (IDX: CPIN) - protein for 280 million people

Indonesia's poultry leader. The free-school-meals programme that worries bank investors adds 5-7% to broiler demand - a natural internal hedge in an Indonesian basket. Margins will normalize; the per-capita protein story is early. Risks: feed costs, normalization.

6. Indofood (IDX: INDF) - the Indomie monopoly at half book

Indomie is close to a de-facto noodle monopoly and one of Asia's most recognizable brands. The discount is structural (holding, country), not operational. Risks: holding discount persistence; wheat/palm oil.

Part III. Dividend + catalyst

7. Telkom Indonesia (NYSE: TLK) - value with a spin-off attached

Indonesia's incumbent telecom after a governance reset. Tower/data-center carve-outs have historically unlocked value across Asian telecoms; here one comes with a 9% yield attached. Risks: price war, timelines.

8. PLDT (NYSE: PHI) - dividends plus a free fintech option

The Philippine telecom leader whose #2 digital bank the market values at zero. Capex peak passed, FCF positive, deleveraging to 2.0x. Risk: leverage 2.56x EBITDA - the highest here.

9. KEGOC (KASE: KEGC) - the grid monopoly after a tariff reset

Half of book value for the national grid with regulated returns flowing through. Last despite best momentum: currency and access fail the USD framework; strong local-book idea. Risk: tariff politics.

Part IV. Commodities - what the model actually likes

Refiners: EBITDA at today's crack spreads vs LTM (label = model upside)
Refiners: EBITDA at today's crack spreads vs LTM (label = model upside)

10. Valero (NYSE: VLO) - the quality way to own the refining cycle

The same thesis that made PBF +36% in three weeks, in institutional form. PBF (+141% model upside) stays the aggressive pure-play; DK (+150%) and PARR (+132%) are the small-cap tail. Risks: crack normalization, product imports.

11. MBRF (B3: MBRF3, ex-BRF + Marfrig) - the new global protein giant

Cheap corn, a weak real and merger synergies compound Brazilian chicken's global cost advantage. Risks: US beef cattle cycle, controlling-shareholder governance, BRL.

12. EQT (NYSE: EQT) - the structural natural gas winner

Not mean-reversion but a multi-year demand story; the latest quarter already beat on volumes and prices. Risks: gas volatility, LNG contracting.

Part V. US Leaders

13. PepsiCo (Nasdaq: PEP) - a dividend king at a decade-high yield

GLP-1 fears pushed a pricing-power franchise to its highest yield in decades; the dividend streak is a hard floor, volume recovery is upside. Risks: structural GLP-1 drag, weak US consumer.

Summary

Three baskets. Buy-now via any US broker: BMRI (PPERY), BBRI (BKRKY), KSPI, TLK, PHI, GFNORTEO (IB direct Mexico), VLO, EQT, PEP. Local-access watchlist: CPIN, INDF (Jakarta), MBRF (B3), KEGOC (KASE). Published and running: PBF +36% since June 25.

Prepared by Enhanced Investments, July 2026, from primary filings, exchange and central-bank data. Live track records, not backtests. Not investment advice.